Skip to main content
← All data ties

ELC infectious-disease capacity in New Jersey

Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) (CFDA 93.323) shows $1,410,759,674.72 in USAspending.gov obligations coded to New Jersey on 2 awards. Two instruments against $1.41 billion produce a mean of about $705.38 million per award. This page joins CDC catalog 93.323 to the NJ geography tag. It is not a lab test, outbreak, or health department census and not cash already paid.

Key figures

  • CFDA 93.323 shows $1,410,759,674.72 in New Jersey obligations on 2 awards.
  • The mean is about $705.38 million per award.
  • The catalog is Epidemiology And Laboratory Capacity For Infectious Diseases (Elc), not immunization cooperative agreements.
  • New Jersey is a place-of-performance tag, not a lab test, outbreak, or health department census.
  • Figures are obligations, not outlays.

ELC cooperative funding tagged to New Jersey

CFDA 93.323 is titled EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC). Filtered to New Jersey place of performance, obligations sum to $1,410,759,674.72 on 2 awards. The national Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) hub includes every state. New Jersey's spending hub includes every program. This tie is the intersection. $1,410,759,674.72 is an obligation aggregate from USAspending.gov, not an outlay and not a count of lab tests, outbreaks, or health departments in Newark, Trenton, or Jersey City.

ELC typically posts as one or two large cooperative-agreement records rather than one row per laboratory. The join does not name recipients, split North Jersey and the shore, or count lab tests, outbreaks, or health departments. Packet facts stop at $1,410,759,674.72, 2 awards, NJ, and 93.323. Correlation is not causation.

93.323 is not immunization cooperative agreements in New Jersey

Immunization Cooperative Agreements (CFDA 93.268) sits on other Catalog numbers. Mixing those dollars into $1,410,759,674.72 would invent a broader total than this 93.323 × NJ cell contains. Facts available: New Jersey, CFDA 93.323, $1,410,759,674.72, 2 awards. Recipient names, subawards, and lab test, outbreak, or health department counts are not in the facts.

The catalog title names Epidemiology And Laboratory Capacity For Infectious Diseases (Elc), not a ranking of New Jersey outcomes. Dividing $1,410,759,674.72 by 2 yields about $705.38 million per award—an ELC cooperative-agreement instrument, not a typical laboratory assay cost. Unique recipients are unpublished. 2 is not a count of lab tests, outbreaks, or health departments.

New Jersey geography on the ELC Infectious Disease Capacity tag

NJ is the place-of-performance code. Awards billed to Newark, Trenton, or Jersey City can share the tag. Awards coded to New York, Pennsylvania, or Delaware stay outside $1,410,759,674.72 even when a metro, watershed, or service area approaches the border. A Trenton-coded cooperative agreement can still cover statewide laboratory work under one NJ tag. The code does not convert $1.41 billion into a lab-capacity map.

New Jersey federal spending is the all-program parent. 93.323 is one row on New Jersey programs. $1.41 billion is not the state's complete federal footprint. Open Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in New Jersey for the filtered table, CFDA 93.323 for 93.323 without a New Jersey filter, and All spending ties for other pairs. Do not add those parents into $1,410,759,674.72.

Reading 2 awards under $1.41 billion

$1,410,759,674.72 ÷ 2 is about $705.38 million per award. That average is an ELC cooperative-agreement instrument, not a typical laboratory assay cost. It is not a median. Net obligations can include downward modifications; the total shown is the aggregate in the facts. Treat 2 as a record count in an aggregate, not as 2 finished ELC awardss.

USAspending obligations can be positive new awards or net of downward modifications; $1,410,759,674.72 is the net total supplied in the facts. Without a transaction register on this page, you cannot see how many of the 2 rows are continuations, renewals, or corrections. Later ingests can restate $1,410,759,674.72 without changing the join key of 93.323 and NJ.

What the ELC Infectious Disease Capacity–New Jersey pair does not prove

A large 93.323 total tagged to New Jersey does not measure case counts, and it does not equal laboratory throughput. FEC donations do not fund this USAspending cell. Correlation is not causation. The headline remains $1,410,759,674.72 on 2 awards for Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in New Jersey.

Keep both sides of the join: Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and New Jersey, obligations only. Do not annualize $1,410,759,674.72 without a year field—this packet publishes none. Do not treat 2 as a lab test, outbreak, or health department census. Quote USAspending.gov and the overlay path rather than a program story.

Using the ELC Infectious Disease Capacity–New Jersey overlay

The overlay target is the New Jersey × CFDA 93.323 table. Open Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) in New Jersey when you want the same $1,410,759,674.72 / 2-awards cell in the site's data chrome. CFDA 93.323 drops the New Jersey filter. New Jersey federal spending drops the CFDA filter. New Jersey programs lists other catalogs beside Epidemiology And Laboratory Capacity For Infectious Diseases (Elc). All spending ties is the directory of other pairs.

This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that New Jersey won or lost federal money, that donations paid for the awards, or that obligations equal cash. The pair is 93.323 plus NJ. Obligations of $1,410,759,674.72 are not outlays. Cite Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) together with New Jersey whenever you reuse $1,410,759,674.72. 2 remains an award-record count on USAspending.gov, not a person, facility, or project census.

Questions

How much ELC funding is obligated in New Jersey?
USAspending.gov shows $1,410,759,674.72 in CFDA 93.323 obligations coded to New Jersey across 2 awards. The join uses the program number and New Jersey place of performance. The total is obligations, not outlays. Keep Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and New Jersey together when citing $1,410,759,674.72.
Is ELC the same as immunization cooperative agreements in New Jersey?
No. This cell is CFDA 93.323 only. Immunization Cooperative Agreements (CFDA 93.268) are other catalogs. Mixing those numbers would invent a total larger than $1,410,759,674.72. 2 is a record count, not a lab test, outbreak, or health department census.
Do 2 awards mean 2 laboratories?
2 is a USAspending award-record count, not a lab test, outbreak, or health department census. The implied mean is about $705.38 million per award. Unique recipients are unpublished. Obligations of $1,410,759,674.72 are not outlays. Keep Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and New Jersey together when citing $1,410,759,674.72. The overlay remains the live 93.323 × NJ table on USAspending.gov.
Do these obligations equal tests processed?
No. $1,410,759,674.72 is an obligation sum. Outlays are a different USAspending series. This packet has no lab test, outbreak, or health department count. Keep the obligation label when citing the pair. Original filings remain on USAspending.gov for this 93.323 × NJ pair.

USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.